CompletedNot Applicable

Epione® Post-Market Clinical Follow-up Study

France55 participantsStarted 2022-04-28

Plain-language summary

Post-Market Clinical Follow-up study in order to consolidate performance and safety data of the EPIONE® device when used for percutaneous procedures in the abdomen

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient \>18 years old, * Patient for whom a CT-guided procedure in abdomen has been prescribed and agreed by a multidisciplinary team of radiologists, surgeons and clinicians, * Patient with a confirmed non-opposition. Exclusion Criteria: * Patient unable to undergo general anesthesia, * Pregnant or breast-feeding females

What they're measuring

Technical Success

Timeframe: Visit 2 - D0 The day of the intervention

Technical Success

Timeframe: Visit 2 - D0 The day of the intervention

Trial details

NCT IDNCT05529979

SponsorQuantum Surgical

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-02-22

Results submitted2025-02-12

View on ClinicalTrials.gov More Cancer Abdomen trials